The evolution of amide 3 into conformationally restricted bicyclic triazolo-piperidine 14-S as a ¦Ã-secretase modulator is described. This is a potential disease modifying anti-Alzheimer¡¯s drug which demonstrated high in vitro and in vivo potency against A¦Â42 peptide, reduced lipophilicity and enhanced brain free fraction compared to the previous series.